Ebola Bundibugyo: Dr. Sarr Advocates African Pharmacopoeia
Alors que l'épidémie d'Ebola Bundibugyo sévit en RDC et en Ouganda, le Dr Moussa Sarr, d'Africa CDC, estime que le continent est mieux préparé qu'en 2014 et plaide pour une mobilisation de la pharmacopée africaine dans la recherche de vaccins et traitements.
Amidst the ongoing Ebola Bundibugyo epidemic in the DRC and Uganda, Dr. Moussa Sarr of Africa CDC has called for greater recognition of African traditional medicine. He believes the continent is better equipped to handle outbreaks now compared to 2014. Dr. Sarr emphasized the importance of leveraging the African pharmacopoeia in the accelerated search for effective vaccines and treatments against the virus. His statement highlights a potential avenue for developing localized health solutions.
This report underscores the ongoing health challenges in Africa and proposes leveraging indigenous knowledge for medical research and treatment.
📌 Kaynak
Bu özet Senegal kaynağından otomatik derlenmiştir. Tamamı için orijinal habere gidin.
Orijinal haberi oku →